cloverleaf bio

At cloverleaf bio, we are developing a new class of engineered #tRNA therapeutics. The rapid programmability, high potency, and specificity of our new tRNA modality gives us the potential to revolutionize oncology therapy.

Join us Friday, May 3rd at 2PM in Hope H-103 (or via zoom) for Cole Lewis' thesis defense titled "Maximizing Therapeutic Protein Yield Through 5' UTR Optimization"

REVALIA BIO “HUMAN ORGAN RESEARCH” AWARD: 2023 @Yale Life Science Pitchfest Wendy V. Gilbert (@WendyGScientist), PhD, Professor of Molecular Biophysics and Biochemistry Project: Developing therapeutic tRNAs to revolutionize cancer therapy

1/ Super grateful to be named to the @ForbesUnder30 Healthcare class of 2024! I'm thrilled to be listed alongside such incredible young innovators, scientists, and entrepreneurs. forbes.com/30-under-30/20…

You can meet with us and the other participating startups on 10.11 during a Networking Mixer with MassBio's innovation ecosystem. Register here: massbio.org/events/listing… the-massbiodrive-f23-cohort/ (3/3)

We’re excited to engage with the Mass Bio community as we continue to develop our therapeutic platform!

We’re proud to announce that Cloverleaf Bio has been chosen to participate in @MassBio’s #MassBioDrive Fall 2023 Cohort! (1/3)

Exciting news from the team at Cloverleaf Bio! We are proud to announce that we won second place in the @2048vc 2023 Biotech Pitch Completion. Thank you to all of the judges, and congrats to the other teams!